Bioventus (BVS) Profit After Tax (2020 - 2026)
Bioventus' (BVS) quarterly Profit After Tax came in at $37.4 million in Q2 2026, up 244.0% on a YoY basis from $10.9 million in Q2 2025, and up 847.19% quarter-over-quarter from $3.9 million in Q1 2026.
Analysis
Bioventus (BVS) Profit After Tax (2020 - 2026) Analysis & Trends
Bioventus (BVS) has reported Profit After Tax for 7 consecutive years, with $37.4 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Profit After Tax rose 244.0% year-over-year to $37.4 million; the trailing twelve-month figure through Jun 2026 stood at $62.6 million (up 2458.42% YoY), and the FY2025 full-year result was $28.1 million, up 154.87% from the prior year.
- Profit After Tax rose to $37.4 million in Q2 2026 per BVS's latest filing, from $3.9 million in the prior quarter.
- Across five years, Profit After Tax topped out at $37.4 million in Q2 2026 and bottomed at -$174.4 million in Q2 2023.
- Historically, Profit After Tax has averaged -$21.8 million across 5 years, with a median of -$6.4 million in 2024.
- The sharpest annual moves came in 2022 and 2025: Profit After Tax tumbled 5429.34% in 2022, then surged 496.53% in 2025.
- Over 5 years, Profit After Tax stood at -$45.2 million in 2022, then surged by 83.08% to -$7.7 million in 2023, then jumped by 43.21% to -$4.3 million in 2024, then soared by 496.53% to $17.2 million in 2025, then soared by 116.79% to $37.4 million in 2026.
- According to Business Quant data, Profit After Tax over the past three periods registered $37.4 million, $3.9 million, and $17.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 1.48 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 1.28 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 905.00 Mn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 241.90 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 249.10 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Bioventus | 1.18 Bn | 1.20 Bn | 105.67 Mn | 37.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | 37.38 Mn |
| Mar 28, 2026 | 3.95 Mn |
| Dec 31, 2025 | 17.24 Mn |
| Sep 27, 2025 | 4.01 Mn |
| Jun 28, 2025 | 10.87 Mn |
| Mar 29, 2025 | -3.32 Mn |
| Dec 31, 2024 | -4.35 Mn |
| Sep 28, 2024 | -5.85 Mn |
| Jun 29, 2024 | -34.64 Mn |
| Mar 30, 2024 | -6.97 Mn |
| Dec 31, 2023 | -7.66 Mn |
| Sep 30, 2023 | -9.12 Mn |
| Jul 1, 2023 | -4.73 Mn |
| Apr 1, 2023 | -174.45 Mn |
| Dec 31, 2022 | -45.24 Mn |
| Oct 1, 2022 | -145.70 Mn |
| Jul 2, 2022 | -8.24 Mn |
| Apr 2, 2022 | -15.09 Mn |
| Dec 31, 2021 | -1.89 Mn |
| Oct 2, 2021 | -2.64 Mn |